checkAd
    Startseite > Aktien > Avid Bioservices > Nachrichten
    Avid Bioservices Aktie
    7,3500
     
    USD
    +0,41 %
    +0,0300 USD
    Letzter Kurs 27.04.24 Nasdaq
    7,3300
     
    USD
    3.300 STK
    Geldkurs 26.04.24
    7,3500
     
    USD
    400 STK
    Briefkurs 26.04.24
    ISIN: US05368M1062 · WKN: A2JBKV · SYM: CDMO · USA

    Neueste Nachrichten

    Avid Bioservices Reports Financial Results for Third Quarter Ended January 31, 2024
    24.04.24 · globenewswire · Avid Bioservices
    Avid Bioservices Announces Receipt of Deficiency Notice from Nasdaq Regarding Late Form 10-Q
    20.03.24 · globenewswire · Avid Bioservices
    Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Avid Bioservices, Inc. (CDMO) on Behalf of Investors
    14.03.24 · Business Wire (engl.) · Avid Bioservices
    Avid Bioservices, Inc. (CDMO) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings
    14.03.24 · Business Wire (engl.) · Avid Bioservices
    INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of Avid Bioservices, Inc. (CDMO) on Behalf of Investors
    14.03.24 · Business Wire (engl.) · Avid Bioservices
    The Law Offices of Frank R. Cruz Announces Investigation of Avid Bioservices, Inc. (CDMO) on Behalf of Investors
    13.03.24 · Business Wire (engl.) · Avid Bioservices
    Avid Bioservices, Inc. (CDMO) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings
    08.03.24 · Business Wire (engl.) · Avid Bioservices
    CDMO LOSS ALERT: ROSEN, A LEADING LAW FIRM, Encourages Avid Bioservices, Inc. Investors to Inquire About Securities Class Action Investigation – CDMO
    07.03.24 · Business Wire (engl.) · Avid Bioservices
    Avid Bioservices Announces Pricing of Private Placement of Convertible Notes
    07.03.24 · globenewswire · Avid Bioservices
    Avid Bioservices Announces Proposed Private Placement of Convertible Notes
    06.03.24 · globenewswire · Avid Bioservices
    Avid Bioservices Announces Certain Preliminary Financial Results for Third Quarter Ended January 31, 2024
    06.03.24 · globenewswire · Avid Bioservices
    Avid Bioservices Partners With California Institute for Regenerative Medicine (CIRM) to Provide CDMO Services for Cell and Gene Therapy (CGT) Programs
    08.11.23 · globenewswire · Avid Bioservices